Anzalone Christopher Richard
Chief Executive Officer · 28 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-01-02 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Sale | 7,416 | $65.88 | $488,566.08 | filing |
| 2026-01-02 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Sale | 5,771 | $66.39 | $383,136.69 | filing |
| 2025-12-29 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Sale | 35,181 | $69.33 | $2.4M | filing |
| 2025-12-29 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Sale | 16,545 | $68.69 | $1.1M | filing |
| 2025-12-29 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Option exercise | 35,181 | $6.15 | $216,363.15 | filing |
| 2025-12-29 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Option exercise | 16,545 | $6.15 | $101,751.75 | filing |
| 2025-12-22 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Sale | 10,012 | $68.33 | $684,119.96 | filing |
| 2025-12-22 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Sale | 2,574 | $68.85 | $177,219.90 | filing |
| 2025-12-19 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Sale | 8,147 | $68.01 | $554,077.47 | filing |
| 2025-12-19 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Sale | 3,979 | $66.67 | $265,279.93 | filing |
| 2025-12-19 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Sale | 1,319 | $68.48 | $90,325.12 | filing |
| 2025-12-17 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Sale | 46,287 | $63.55 | $2.9M | filing |
| 2025-12-17 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Sale | 35,750 | $64.51 | $2.3M | filing |
| 2025-12-17 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Sale | 1,981 | $66.30 | $131,340.30 | filing |
| 2025-12-17 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Sale | 982 | $65.53 | $64,350.46 | filing |
| 2025-12-16 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Sale | 14,095 | $62.12 | $875,581.40 | filing |
| 2025-12-16 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Sale | 10,963 | $61.25 | $671,483.75 | filing |
| 2025-12-16 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Sale | 8,476 | $62.94 | $533,479.44 | filing |
| 2025-12-16 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Sale | 8,416 | $60.51 | $509,252.16 | filing |
| 2025-12-16 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Sale | 6,661 | $64.29 | $428,235.69 | filing |
| 2025-12-16 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Sale | 3,221 | $67.87 | $218,609.27 | filing |
| 2025-12-16 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Sale | 1,300 | $65.77 | $85,501.00 | filing |
| 2025-12-16 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Sale | 1,000 | $64.96 | $64,960.00 | filing |
| 2025-12-16 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Sale | 166 | $66.77 | $11,083.82 | filing |
| 2025-12-15 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Sale | 100,532 | $68.67 | $6.9M | filing |
| 2025-12-15 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Sale | 21,321 | $69.28 | $1.5M | filing |
| 2025-12-15 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Sale | 8,147 | $69.96 | $569,964.12 | filing |
| 2025-12-12 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Award | 180,000 | $0.00 | $0.00 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.